Technical / White Paper

Reducing The Risk During Cell And Gene Therapy Development And Manufacturing

Format: PDF file | Document type: Technical / White Paper

Reducing The Risk During Cell And Gene Therapy Development And Manufacturing

While new modalities are generating significant excitement among patients and caregivers, cell and gene therapy manufacturers are experiencing growing pains. The rapid growth and continued momentum of the industry has led to the issuance of new guidance. In this article we share insights for navigating within a novel and complex regulatory environment, mitigating risks posed by raw materials and implementing proper risk assessments during manufacturing.

Related resources from MilliporeSigma - Gene Therapy

Show more

Supplier info centre